Premium
Antiarrhythmic Therapy: Clinical Pharmacology Update
Author(s) -
WOOSLEY RAYMOND L.,
CERSKUS IRENE,
RODEN DAN M.
Publication year - 1984
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1984.tb01838.x
Subject(s) - medicine , drug , concomitant , pharmacology , clinical pharmacology , disposition , intensive care medicine , psychology , social psychology
Currently available antiarrhythmic agents are limited by side effects and the potential for increasing arrhythmias. In addition, drug interactions, altered disposition of drug as a result of changes in protein binding or concomitant disease processes, active metabolites, and poorly defined therapeutic ranges with great interpatient variability are some of the factors which complicate therapy. An awareness of the possible contribution of these factors in the use of antiarrhythmics is invaluable in both the choice of agent and the establishment of an optimum benefit‐to‐risk ratio for the patient.